The rise of Sildenafil initially sparked a period of growth for the drug industry, but recent developments present a complicated outlook for those considering a stake. Off-patent alternatives are reducing profits, and https://jonasqjud923510.blog2freedom.com/41285077/sildenafil-and-big-pharma-a-risky-play